Skip to main content

Curis Inc

CRIS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001108205

No open-market purchases or sales by Curis Inc insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $7.96M in total; Maverick Capital is the only superinvestor holding it.

Q3 2022 vs. Q2 2022

How the institutions holding Curis Inc changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of CRIS: Q2 2022 compared with Q3 2022
MeasureQ2 2022Of which not filed for Q3 2022Q3 2022Change
Holders91175−15
Shares43.2M1.81K37.3M−5.91M (−13.7%)
Value$42.6M$0$26.2M−$16.4M (−38.5%)

1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (6)

Institutions that held Curis Inc at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to CRIS in Q3 2022
InstitutionSharesValue% of portfolio
Jacobs Levy Equity Management, Inc1,354,859$948.0K0.01%
Ally Bridge Group (NY) LLC264,023$185.0K0.12%
Charles Schwab Investment Management Inc57,090$40.0K0.00%
Mariner, LLC19,044$13.0K0.00%
Axiom Investment Management LLC4,000$2.00K0.00%
China Universal Asset Management Co., Ltd.860$1.00K0.00%

Sold out (21)

Institutions that held Curis Inc at the end of Q2 2022 and filed for Q3 2022 without it.

Not filed for Q3 2022 yet (1)

Institutions that held Curis Inc at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CRIS in Q2 2022 that haven't filed for Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
B. Riley Wealth Management, Inc.1,806–